NDC 16262-601-44 - Alendronate Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16262-601
- Requested NDC
- 16262-601-44
- Package NDCs from labels
- 16262-601-44
- Manufacturer
- Dispensing Solutions Inc.
- Effective date
- 2010-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALENDRONATE SODIUM TABLETS, USP | Dispensing Solutions Inc. | 2010-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ACTIVE INGREDIENT | 2UY4M2U3RA | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 | |
| alendronic acid | ACTIVE MOIETY | X1J18R4W8P | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALENDRONATE SODIUM TABLET [DISPENSING SOLUTIONS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alendronate Sodium | ALENDRONATE SODIUM | A-S Medication Solutions | 873442b0-1932-4fa6-ba25-b4d3505f4128 | 2024-11-13 | Warnings, Adverse reactions | 2UY4M2U3RA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EXELAN PHARMACEUTICALS INC. | 91a0f73a-d8cd-4197-b431-40707a2150b9 | 2023-08-25 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Proficient Rx LP | 6c4d13fb-490c-4ea9-9b04-003c8d8e9f0c | 2023-03-01 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Amneal Pharmaceuticals of New York LLC | c23fb7fe-c6b9-4f77-bde7-992222b589d3 | 2021-02-02 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| 8de3b358-74d1-485b-bf3d-f70a6140bf81 | 62af73fb-c9b7-4034-9794-dbb50420e62b | 2010-01-28 | Warnings, Adverse reactions | 8de3b358-74d1-485b-bf3d-f70a6140bf81 62af73fb-c9b7-4034-9794-dbb50420e62b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.